CXorf22 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84738
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human CXorf22. Peptide sequence: VGLPQAPPPKSPPVVIQCQSRKRAEEKVEIILNAGFFGFSLTPDLTEVLV The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for CXorf22 Antibody
![Western Blot: CXorf22 Antibody [NBP2-84738]](https://resources.bio-techne.com/images/products/CXorf22-Antibody-Western-Blot-NBP2-84738-img0001.jpg "Western Blot: CXorf22 Antibody [NBP2-84738]")
Western Blot: CXorf22 Antibody [NBP2-84738]
Western Blot: CXorf22 Antibody [NBP2-84738] - Host: Rabbit. Target Name: CXorf30. Sample Type: Fetal Liver lysates. Antibody Dilution: 1.0ug/mlApplications for CXorf22 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CXorf22
Alternate Names
Calponin Homology Domain Containing 2, Calponin Homology Domain-Containing Protein 2, CHDC2, chromosome X open reading frame 22, Chromosome X Open Reading Frame 30, chromosome X open reading frame 59, Cilia And Flagella Associated Protein 47, Cilia- And Flagella-Associated Protein 47, CXorf30, CXorf59, MGC34831
Gene Symbol
CFAP47
Additional CXorf22 Products
Product Specific Notices for CXorf22 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...